Novel therapy improves cardiovascular health in central sleep apnea patients

May 16, 2011

Researchers have demonstrated the effectiveness of a novel treatment that stimulates the nerve that controls the diaphragm to normalize the breathing of patients who suffer from both heart failure and central sleep apnea.

"Many heart failure patients suffer from central , which a number of studies have shown increases mortality in these patients," said Shahrokh Javaheri, MD, professor emeritus of medicine at the University of Cincinnati and medical director of Sleepcare Diagnostics in Mason, Ohio.

Systolic heart failure describes a in which the heart no longer pumps blood strongly enough to meet the body's needs. According to the , the number of Americans living with heart failure is estimated at 5.8 million—a number that is expected to grow as people live longer and the population ages. Heart failure is also the leading cause of hospitalization among Medicare patients

Dr. Javaheri and his colleagues will present the results of their study, "Single Night Transvenous Nerve Stimulation Improves Central Sleep Apnea in Systolic Heart Failure Patients," during the ATS 2011 International Conference, in Denver.

In this study, Dr. Javaheri and his colleagues conducted an acute, prospective investigation of 16 patients with a mean age of 59 and a mean body mass index of 27 kg/mk2. All 16 patients were diagnosed with (mean left ventricular ejection fraction of 30 percent) and central sleep apnea.

The patients served as their own control group, receiving on one night phrenic nerve stimulation and no therapeutic intervention on another. The intervention, which acts like a pacemaker for the nerve, dramatically reduced the number of times patients stopped, or almost stopped, breathing; improved blood oxygenation levels while sleeping; and resulted in a healthier heart rate.

Compared to the control night, phrenic nerve stimulation resulted in the virtual elimination of central sleep apnea as measured by the central apnea Index (25 ± 14 vs. 3 ± 4/hour, p ≤0.001). There was a significant decrease in the apnea-hypopnea index (47 ± 12 vs. 24 ±15/hour, p=0.002) and in the associated arousal index (32 ±12 vs. 16 ±10/hour, p=0.001) and in the reduced number of times the patient experienced 4 percent oxygen desaturation (31 ± 11 vs. 16 ± 12/hour, p=0.002). Overnight sleep heart rate decreased significantly (73.3 ± 17.1 vs. 71.1 ± 16.3 bpm, p=0.002).

The current best treatment for these patients is Continuous Positive Airway Pressure (CPAP). In about half of all patients, CPAP suppresses central sleep apnea and improves cardiovascular health and mortality, according to Dr. Javaheri. However, even among those patients that could be helped by CPAP, many cannot tolerate sleeping an entire night with a nasal mask, so the percentage of patients helped by CPAP is considerably lower.

"Our research suggests," said Dr. Javaheri, "that there is a new therapy—one that, unlike CPAP and other existing mask-based therapies, could be tolerated by all ."

Dr. Javaheri added that a randomized clinical trial is now needed to determine the clinical implications on long-term phrenic nerve stimulation on morbidity and of with central apnea.

Explore further: CPAP decreases cardiovascular mortality in elderly patients

Related Stories

CPAP decreases cardiovascular mortality in elderly patients

May 15, 2011
Continuous positive airway pressure (CPAP) effectively decreases the risk of cardiovascular death in elderly patients who suffer from obstructive sleep apnea (OSA), according to a study conducted by researchers in Spain. ...

Recommended for you

Anti-nausea drug could help treat sleep apnea

June 6, 2017
An old pharmaceutical product may be a new treatment for obstructive sleep apnea, according to new research presented today by University of Illinois at Chicago and Northwestern University scientists at the SLEEP 2017 annual ...

New disposable, wearable patch found to effectively detect sleep apnea

June 4, 2017
Results of a definitive clinical trial show that a new, disposable diagnostic patch effectively detects obstructive sleep apnea across all severity levels.

Childhood sleep apnoea is common but hard to diagnose

April 28, 2017
The cessation of breathing during sleep caused by enlarged tonsils is common in preschool-age children and can cause serious complications, but the methods normally used to diagnose the condition are subjective and unreliable. ...

Curbing sleep apnea might mean fewer night trips to bathroom

March 27, 2017
(HealthDay)—Millions of Americans battle bothersome nighttime conditions, such as sleep apnea or the need to get up frequently to urinate.

Untreated sleep apnea in children can harm brain cells tied to cognition and mood

March 17, 2017
A study comparing children between 7 and 11 years of age who have moderate or severe obstructive sleep apnea to children the same age who slept normally, found significant reductions of gray matter - brain cells involved ...

Dietary supplement derived from tree bark shows promise for treating obstructive sleep apnea

February 24, 2017
Obstructive sleep apnea, which causes people to briefly stop breathing while asleep, affects an estimated 5 percent of the population, not including the many more who don't even realize they suffer from the disorder.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.